Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Benefits of blinded continuous glucose monitoring during a randomized clinical trial.

Muchmore D, Sharp M, Vaughn D.

J Diabetes Sci Technol. 2011 May 1;5(3):676-80.

2.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
3.

Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: a feasibility study.

Logtenberg SJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ.

Diabetes Technol Ther. 2009 May;11(5):293-9. doi: 10.1089/dia.2008.0088.

PMID:
19425877
4.

The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.

Ehrhardt NM, Chellappa M, Walker MS, Fonda SJ, Vigersky RA.

J Diabetes Sci Technol. 2011 May 1;5(3):668-75.

5.

Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L.

Diabetes Care. 2006 Jan;29(1):44-50.

PMID:
16373894
6.

Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.

Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.

Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170. Review.

7.

New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time.

Bailey T, Zisser H, Chang A.

Diabetes Technol Ther. 2009 Dec;11(12):749-55. doi: 10.1089/dia.2009.0075.

PMID:
20001675
8.

Comparison of the clinical information provided by the FreeStyle Navigator continuous interstitial glucose monitor versus traditional blood glucose readings.

McGarraugh GV, Clarke WL, Kovatchev BP.

Diabetes Technol Ther. 2010 May;12(5):365-71. doi: 10.1089/dia.2009.0136.

PMID:
20388046
9.

Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.

Kropff J, Choudhary P, Neupane S, Barnard K, Bain SC, Kapitza C, Forst T, Link M, Dehennis A, DeVries JH.

Diabetes Care. 2017 Jan;40(1):63-68. doi: 10.2337/dc16-1525. Epub 2016 Nov 4.

PMID:
27815290
10.

Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?

Fabris C, Patek SD, Breton MD.

J Diabetes Sci Technol. 2015 Aug 14;10(1):50-9. doi: 10.1177/1932296815599177.

12.

Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.

Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M.

Diabetes Care. 2009 Dec;32(12):2245-50. doi: 10.2337/dc09-0750. Epub 2009 Sep 18.

13.

Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.

Radermecker RP, Fayolle C, Brun JF, Bringer J, Renard E.

Diabetes Metab. 2013 May;39(3):258-62. doi: 10.1016/j.diabet.2012.12.004. Epub 2013 Mar 19.

PMID:
23522730
15.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
16.

Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study.

Mahmoudi Z, Johansen MD, Nørgaard HH, Andersen S, Pedersen-Bjergaard U, Tarnow L, Christiansen JS, Hejlesen O.

J Diabetes Sci Technol. 2015 Jun 8;9(5):1092-102. doi: 10.1177/1932296815587935.

17.

Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus.

Floyd B, Chandra P, Hall S, Phillips C, Alema-Mensah E, Strayhorn G, Ofili EO, Umpierrez GE.

J Diabetes Sci Technol. 2012 Sep 1;6(5):1094-102. Review.

18.
19.

Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy.

Schaupp L, Donsa K, Neubauer KM, Mader JK, Aberer F, Höll B, Spat S, Augustin T, Beck P, Pieber TR, Plank J.

Diabetes Technol Ther. 2015 Sep;17(9):611-8. doi: 10.1089/dia.2014.0343. Epub 2015 Apr 30.

PMID:
25927357
20.

Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes.

Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM.

Diabetes Care. 2012 Jan;35(1):32-8. doi: 10.2337/dc11-1438. Epub 2011 Nov 18.

Supplemental Content

Support Center